These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8834707)

  • 1. Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril.
    Moore TJ; Rich G; McKnight JA; McCullough M; Hollenberg NK
    Am J Hypertens; 1996 Jan; 9(1):54-60. PubMed ID: 8834707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II.
    Chamarthi B; Williams JS; Williams GH
    J Hypertens; 2010 May; 28(5):1020-6. PubMed ID: 20216091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension.
    Fliser D; Nowack R; Wolf G; Ritz E
    Blood Press; 1993 Dec; 2(4):296-300. PubMed ID: 8173699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril.
    Bursztyn M; Gavras I; Gourley L; DeSilva J; Whalen J; Gavras H
    Clin Ther; 1994; 16(3):429-36. PubMed ID: 7923309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension.
    Karnik ND; Oza YK; Sane SP; Kaushik R; Bhatt AD; Chawla KP; Vaidya AB; Yajnik VH; Khokhani RC
    J Assoc Physicians India; 1998 Mar; 46(3):283-5. PubMed ID: 11273348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men.
    Noormohamed FH; Fuller GN; Lant AF
    J Clin Pharmacol; 1989 Oct; 29(10):928-37. PubMed ID: 2687336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of salt intake on target organ damages in treated hypertensive patients.
    Ohta Y; Tsuchihashi T; Kiyohara K
    Clin Exp Hypertens; 2012; 34(5):316-20. PubMed ID: 22804491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.
    Roman MJ; Alderman MH; Pickering TG; Pini R; Keating JO; Sealey JE; Devereux RB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):387-96. PubMed ID: 9607375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
    du Cailar G; Fesler P; Ribstein J; Mimran A
    Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benazepril on stress testing blood pressure in essential hypertension.
    Cardillo C; Mores N; Motolese M; Folli G
    Am J Cardiol; 1994 Feb; 73(5):368-73. PubMed ID: 8109551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
    Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M
    Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction.
    Reams GP; Lau A; Bauer JH
    J Clin Pharmacol; 1989 Jul; 29(7):609-14. PubMed ID: 2668351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.